Skip to content

Comprehensive Segmental Revision System

Degenerative Disease | Oncology | Revision Surgery | Trauma | Rheumatoid Arthritis

Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:

* Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity
* Oncology applications including bone loss due to tumour resection

Exclusion Criteria:

* Sepsis ( active)
* Infection ( active)
* Osteomyelitis (active)

Lieu de l'étude

Nova Scotia Health Authority
Nova Scotia Health Authority
Halifax, Nova Scotia
Canada

Contactez l'équipe d'étude

Primary Contact

Kelly Trask

Étude parrainée par
Zimmer Biomet
Participants recherchés
Plus d'informations
ID de l'étude: NCT03270982